In this study, the authors show that machine learning is a useful tool for complex pathological assessment of Alzheimer disease and other tauopathies. Using deep learning classifiers, we now have the potential to integrate cell- and region-specific annotations with clinical, genetic, and molecular data, providing unbiased data for clinicopathological correlations that will enhance our knowledge of the neurodegeneration.
- Maxim Signaevsky
- Marcel Prastawa
- John F. Crary
